Despite Promising Laboratory Data Bone Cancer Treatment Ineffective
Ewing sarcoma is the second most common type of primary bone cancer seen in children and young adults. Patients with relapsed or refractory Ewing sarcoma have a poor outcome with conventional therapies. Cytarabine decreases the levels of a certain key protein in Ewing sarcoma cells and has demonstrated preclinical activity against Ewing sarcoma cell lines in the laboratory. Treatment of Ewing sarcoma that relapses is difficult.
Original post by Allergy News From Medical News Today
No comments
Related Articles
Study Finds Bortezomib To Be Promising Treatment For Rheumatoid Arthritis
Treatment Of Rare Type Of Bone Tumour: Promising Results With Denosumab
What Is Bone Cancer (Sarcoma)? What Causes Bone Cancer?
Hope For A New Treatment For Bone Cancer
Promising Data On Head And Neck Cancer Announced By DNAR At 2008 American Society Of Clinical Oncology Meeting
Study Finds Bortezomib To Be Promising Treatment For Rheumatoid Arthritis
Treatment Of Rare Type Of Bone Tumour: Promising Results With Denosumab
What Is Bone Cancer (Sarcoma)? What Causes Bone Cancer?
Hope For A New Treatment For Bone Cancer
Promising Data On Head And Neck Cancer Announced By DNAR At 2008 American Society Of Clinical Oncology Meeting